Brief: Abcellera Receives Authorization From Health Canada To Initiate Phase 1 Clinical Trial Of ABCL575
May 30 (Reuters) - Abcellera Biologics Inc ABCL.O: ABCELLERA RECEIVES AUTHORIZATION FROM HEALTH CANADA TO INITIATE A PHASE 1 CLINICAL TRIAL OF ABCL575 ABCELLERA BIOLOGICS INC - PHASE 1 CLINICAL TRIAL FOR ABCL575 TO START IN Q3 2025 Source text: ID:nBw4WscWBa Further company coverage: ABCL.O (((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on AbCellera Biologics
See all newsAbCellera Biologics Inc. reports results for the quarter ended September 30 - Earnings Summary
Canada's AbCellera Q3 revenue beats analyst estimates
Factbox: Pharma sector doubles down on AI to slash costs, timelines
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce